Megapharm Ltd. Competitors

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Harel Insurance Investments & Financial Services LTD. is one of Israel's largest insurance and finance groups that provides comprehensive financial and insurance solutions. As of March 31, 2019, the Group manages assets over NIS 250 billion. Founded as a family business in 1935 by the late Ernst and Margot Hamburger, Harel Insurance Investments & Financial Services has become one of Israel’s largest insurance groups. Their comprehensive product portfolio includes health, life, business, and motor insurance as well as investment services such as pension and mutual funds. Despite the fact Harel is now a publicly traded company with more than 5,000 employees, they retain their traditional family values including an emphasis on personalized service and reliability In 2015, Harel announced a new strategy to "recalculate routes" transform for the digital era. Seeking to provide agents customers with simpler, faster, and more personal service, our strategy involved digitizing processes and data driven to improve the speed and quality of service as well as expanding the use of analytics. Harel insures the Israeli branches of numerous multinational corporations and is a “Global Partner” of large insurance conglomerates, such as Zurich, Allianz, AXA, Royal & Sun Alliance, XL-Catlin, HDl-Gerling, QBE, If P&C, Sompo Japan Nipponkoa Insurance and Chubb.

Kamada is a growing commercial-stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions. The company is a leader in the specialty plasma-derived field focused on diseases with limited treatment alternatives, with 6 FDA-approved products selling in over 30 countries. The company is advancing an innovative development pipeline targeting areas of significant unmet medical need.